Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MCK
MCK logo

MCK Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy McKesson Corp (MCK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
756.470
1 Day change
0.27%
52 Week Range
999.000
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

McKesson is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The stock has some constructive signals, but the current setup is mixed: technicals are not fully bullish, options sentiment is mildly positive, and analysts remain broadly supportive, yet insider selling and a recent lack of fresh catalysts make this more of a hold than an immediate buy. At the current pre-market price around 767.6, I would not call it an urgent buy.

Technical Analysis

Current price is 767.6 in pre-market, slightly above the pivot of 752.052 and below resistance at 774.514. MACD histogram is positive and expanding, which supports short-term momentum, but RSI_6 at 52.66 is neutral and does not show strong upside pressure. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend is still not fully aligned bullishly. Overall, the price is trying to improve, but the trend is not strong enough to justify an aggressive long-term entry today.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is modestly bullish. The put-call ratios below 1 suggest more call interest than put interest, with open interest put-call ratio at 0.59 and volume put-call ratio at 0.82. Implied volatility is moderate at 26.11 with IV rank 14.52, suggesting options are not pricing in extreme uncertainty. Volume is also well above average, but without a strong proprietary signal, this is supportive rather than decisive.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
0

Positive Catalysts

  • ["Analyst ratings remain broadly positive, with multiple Buy/Outperform/Overweight ratings maintained.", "UBS raised its target to $1,050, showing continued confidence in upside potential.", "William Blair initiated coverage with Outperform, citing a durable competitive moat and specialty-led growth upside.", "Options flow is mildly bullish based on put-call ratios below 1.", "MACD momentum is positive and expanding, suggesting near-term technical improvement."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh event-driven catalyst.", "Several analysts lowered price targets, including Citi, Deutsche Bank, Baird, JPMorgan, Evercore, and BofA.", "Evercore previously placed the stock on a Tactical Underperform list.", "Insiders are selling, and selling activity increased 144.45% over the last month.", "Congress trading data shows 1 sale and 0 purchases in the last 90 days, signaling caution.", "The moving average structure is still bearish, which weakens the current trend."]

Financial Performance

No usable latest-quarter financial snapshot was provided due to an error, so a detailed quarterly assessment is not available. Based on the analyst commentary, McKesson recently had a mixed Q4/Q1-type print, but management's FY27 outlook and long-range plan were viewed positively by several analysts. That suggests the underlying business remains fundamentally solid, though recent reported results were not cleanly accelerating.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Wall Street remains generally constructive on McKesson, with Citi, UBS, Deutsche Bank, Baird, JPMorgan, Evercore, BofA, and William Blair all maintaining bullish or positive ratings overall. However, the recent trend in price targets is mixed-to-lower, with several firms trimming targets after results, while UBS increased its target. In short, pros still like the business and moat, but the near-term sentiment has cooled because of a mixed quarter and lower target revisions.

Wall Street analysts forecast MCK stock price to rise
14 Analyst Rating
Wall Street analysts forecast MCK stock price to rise
12 Buy
2 Hold
0 Sell
Strong Buy
Current: 756.980
sliders
Low
880
Averages
942.83
High
1000
Current: 756.980
sliders
Low
880
Averages
942.83
High
1000
Citi
Buy
to
Buy
downgrade
$975 -> $945
AI Analysis
2026-05-14
Reason
Citi
Price Target
$975 -> $945
AI Analysis
2026-05-14
downgrade
Buy
to
Buy
Reason
Citi lowered the firm's price target on McKesson to $945 from $975 and keeps a Buy rating on the shares.
UBS
Kevin Caliendo
Buy
maintain
2026-05-08
Reason
UBS
Kevin Caliendo
Price Target
2026-05-08
maintain
Buy
Reason
UBS analyst Kevin Caliendo raised the firm's price target on McKesson to $1,050 from $1,000 and keeps a Buy rating on the shares. Despite the "messy" Q4 print, the initial FY27 outlook looks "good enough," the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MCK
Unlock Now

People Also Watch